SCHEMBL16692850

SCHEMBL16692850

Clc1ncc2c(n1)N(Cc1ccccc1Cl)CCO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A13 Q16696 2/20 0.43
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ RAB9A P51151 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ GPR35 Q9HC97 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ TSHR P16473 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16691340 0.86 GRM5 (0.41) CYP2D6ALDH1A1GAAMAPT
SCHEMBL16692869 0.85 CNR2 (0.44) POLBKMT2ANPSR1KDM4EALDH1A1
SCHEMBL16692848 0.81 PKM (0.39) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL30443099 0.79 TNIK (0.44) CYP1A2CYP3A4CYP2C19RAB9AMEN1
SCHEMBL16692866 0.79 TNIK (0.44) CYP1A2CYP3A4CYP2C19RAB9AMEN1
SCHEMBL16692858 0.78 CYP2C9 (0.43) CYP3A4CYP2D6CYP2C19SIGMAR1CLPP
SCHEMBL16692838 0.78 GRM5 (0.41) CYP1A2CYP2D6CLPPMAPT
SCHEMBL16692826 0.76 TNIK (0.46) SMN1; SMN2KDM4EALDH1A1SIRT2SIRT1
SCHEMBL16691277 0.75 PSEN1 (0.49) POLBGAAMAPT
SCHEMBL16692874 0.74 ROCK2 (0.50) KDM4EALDH1A1GAADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066697-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-05-07 — — WO disclosed
Send feedback